News
10-13-2021, 09:30 PM
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.
More... (https://www.news-medical.net/news/20211013/MR-guided-focused-ultrasound-can-safely-deliver-antibody-therapy-to-Her2-positive-brain-metastases.aspx)
More... (https://www.news-medical.net/news/20211013/MR-guided-focused-ultrasound-can-safely-deliver-antibody-therapy-to-Her2-positive-brain-metastases.aspx)